Sunday, July 21, 2013

Inside Health Policy July 22, 2013 PhRMA Criticizes Senate Drug Compounding Bill As Others Also Take Sides


The Pharmaceutical Research and Manufacturers of America this week spoke out against a Senate proposal to create a third regulatory category that encompasses non-traditional drug compounding.


No comments: